National
Latin American LGBT activists visit the U.S. on State Department-sponsored trip
Nine Central and South American LGBT activists will remain in the country through Sept. 22
Laura Bronzino of Argentina and Jaime Parada in Chile in D.C. (Washington Blade photo by Michael K. Lavers)
Nine Latin American activists continue to tour the United States on a State Department-organized trip that is part of its ongoing efforts to promote human rights for LGBT people around the world.
Jaime Parada of the Movement for Homosexual Integration and Liberation in Chile; Laura Bronzino, president of the Misiones LGBT Association in Argentina; Henry Peralta, general director of the LGBT Equality Foundation in Bolivia; Marcela Sánchez, executive director of Colombia Diversa; Brazilian Congressman Jean de Matos; Francisco Madrigal of the Center for the Investigation and Promotion of Human Rights in Central America in Costa Rica; Efraín Soria, president of the Equity Foundation in Ecuador; José Lopéz, vice president of Comunidad Cultural de Tijuana LGBTI in México and Panamanian activist Augustín Rodríguez began their trip in D.C. on Sept. 4. They met with Human Rights Campaign staffers, former HRC President Elizabeth Birch, Council for Global Equality President Mark Bromley, transgender activist Dr. Dana Beyer and gay Maryland state Del. Luke Clippinger (D-Baltimore City,) representatives from the Justice Department, the Inter-American Commission on Human Rights and other federal agencies, human rights groups and non-governmental organizations while in the nation’s capital. The group also discussed the repeal of the military’s ban on openly gay and lesbian servicemembers at the Pentagon.
The activists met with staffers and representatives from the Gay and Lesbian Alliance Against Defamation, Harvey Milk High School, the American Civil Liberties Union, the New York City Anti-Violence Project and Gay Men’s Health Crisis while in the Big Apple from Sept. 8-12.
The group is scheduled to meet with representatives of the San Francisco LGBT Community Center, Equality California, the Transgender Law Center, the Gay-Straight Alliance Network and COLAGE while in the Bay Area from Sept. 12-16. Activists are also slated to meet with the University of Louisville’s Office of LGBT Services staffers and PFLAG members while in Kentucky from Sept. 16-19. And they are scheduled to meet with members of the Unity Coalition and Walker Burttschell, a former Marine infantryman who was discharged under “Don’t Ask, Don’t Tell” in 2003, in Miami before they leave the country on Sept. 22.
“I am tremendously happy for this experience that I will live,” said Parada in a press release his organization released before he arrived in the United States on Sept. 1. “It will be a big help in amplifying and perfecting my fight for the human rights of [Chile’s] sexual diversity. Without a doubt, the experiences and knowledge that I will gain will benefit sexual minorities.”
Latin American countries expand rights to LGBT citizens
Central and South American countries have also begun to expand rights to their LGBT citizens.
Same-sex couples in Mexico City have been able to marry and adopt children since 2010 — the Mexican Supreme Court ruled the same year that the country’s 31 other states must recognize them. Gays and lesbians have been able to enter into civil unions in the Mexican state of Coahuila since 2007.
Ecuador and Uruguay also allow civil unions for same-sex couples. Colombia also recognizes these relationships, but gays and lesbians will automatically receive full marriage rights in June 2013 if the country’s lawmakers do not act upon a court ruling that orders them to legislate the matter.
Argentine President Cristina Fernández signed her country’s same-sex marriage law in 2010, while neighboring Uruguay is widely expected to become the next Latin American country to allow gays and lesbians to tie the knot. São Paolo and several other Brazilian cities and states have recognized hundreds of same-sex civil unions in response to a 2011 ruling from the country’s Supreme Court.
Chilean President Sebastián Piñera pledged ahead of the country’s 2010 presidential election that he supports civil unions for same-sex couples. He introduced a civil unions measure last year, but it has stalled in the Chilean Congress.
“Marriage is uncertain,” Parada told the Blade. “It will undoubtedly be one of the most important points in the next presidential election, but it is very uncertain what will happen in that regard.”
Lawmakers pass transgender rights, anti-hate crimes bills
In addition to marriage, attitudes towards anti-LGBT discrimination and other issues in Latin America continue to change.
Piñera in July signed an LGBT-inclusive hate crimes and anti-discrimination bill that had languished for seven years. Chilean lawmakers passed the measure in response to four self-described neo-Nazis who allegedly beat Daniel Zamudio to death in a park in Santiago, the country’s capital, because he was gay.
Parada noted to the Blade that Santiaguïnos marched in the streets nearly every day to show their solidarity with Zamudio in the days and weeks after the brutal attack that left him in a coma. He ultimately succumbed to his injuries, but Parada noted the media coverage that surrounded Zamudio’s death highlighted efforts to combat anti-LGBT discrimination and violence in the country.
“It started a small ‘click’ in the people’s minds,” he said. “This case was an earthquake of a loss of a human life, but it was a point of inflection.”
In neighboring Argentina, Fernández in May signed a law that allows people who have not undergone sex-reassignment surgery to legally change their gender without a doctor or judge’s approval. It further mandates public and private health insurance plans to cover SRS, hormone therapy and other trans-specific treatments without additional premiums.
Bronzino, who is from northeastern Argentina near Iguazu Falls, acknowledged the same-sex marriage and gender identification laws to the Blade. She stressed that anti-LGBT police violence and discrimination remain problems.
Bronzino further noted that a lot of people have yet to benefit from these new legal protections.
“Equality has taken root in this country and the LGBT gender change,” she said. “But in Misiones they are not relevant. Only 15 equal marriages and 13 LGBT gender changes [have taken place.] That is not a large number of people.”
Activists: Trip proves Clinton’s commitment to global LGBT rights
The State Department did not return the Blade’s request for comment on the trip, but those who met with the activists applauded their efforts.
“They’re a great group of people who are all very active in their countries,” said Mónica Trasandes, GLAAD’s director of Spanish language media. “There is so much going on in Latin America now — Mexico and Central and Latin America. It’s wonderful and exciting to see that.”
“It was a pleasure to support the work of the State Department and all of the committed activists visiting the U.S. hoping to take lessons learned from our movement and apply them for positive change in their home countries,” added HRC spokesperson Michael Cole-Schwartz.
Beyer, who met with the activists in Annapolis after she returned from the Democratic National Convention in Charlotte, further described the trip as proof what she said is the former First Lady’s ongoing commitment to LGBT rights.
“Secretary Clinton came out and said LGBT rights are human rights and human rights are LGBT rights,” she told the Blade. “She wasn’t just talking. She’s made it real. This is an implementation of that policy of treating LGBT rights as human rights.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Long-awaited ‘Pillion’ surpasses the sexy buzz
Reasons to be optimistic about 2026
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Using movement to boost your mental health during holidays
